ACMD drug-specific reports

Collection

ACMD drug-specific reports

This series brings together all documents relating to ACMD drug-specific reports.

From:: Advisory Council on the Misuse of Drugs
Published: 4 June 2013

皇冠体育app Advisory Council carries out in-depth reviews of specific drugs, including their classification under the Misuse of Drugs Act 1971.

Documents

Ketamine: rescheduling and patient group directions
- 17 February 2015
- Policy paper
Ketamine report
- 10 December 2013
- Policy paper
Temporary class drug order on benzofury and NBOMe compounds - letter from ACMD
- 4 June 2013
- Correspondence
ACMD advice on tramadol
- 13 February 2013
- Research and analysis
ACMD advice on independent prescribing of controlled drugs
- 13 February 2013
- Guidance
Khat report 2013
- 12 February 2013
- Research and analysis
ACMD - Recovery from drug and alcohol dependence: an overview of the evidence (2012)
- 9 January 2013
- Research and analysis
Advisory Council on the Misuse of Drugs (ACMD) Methoxetamine report, 2012
- 18 October 2012
- Policy paper
Novel psychoactive substances report (2011)
- 25 October 2011
- Research and analysis
ACMD report on desoxypipradrol
- 13 September 2011
- Correspondence
Foil report
- 10 November 2010
- Research and analysis
Advisory Council on the Misuse of Drugs: Consideration of the anabolic steroids
- 21 September 2010
- Corporate report
Advisory Council on the Misuse of Drugs: Consideration of the anabolic steroids
- 21 September 2010
- Research and analysis
Advisory Council on the Misuse of Drugs Naphyrone Report (2010)
- 7 July 2010
- Research and analysis
ACMD report on the consideration of the cathinones
- 31 March 2010
- Policy paper
ACMD report on the major cannabinoid agonists
- 12 August 2009
- Independent report
ACMD 1-benzylpiperazine (BZP) Report (2008)
- 21 May 2009
- Independent report
MDMA ('ecstasy') review
- 11 February 2009
- Guidance
ACMD report on gamma-butyrolactone (GBL)
- 6 August 2008
- Guidance
ACMD: Cannabis classification and Public Health (2008)
- 7 May 2008
- Corporate report
ACMD Drug Facilitated Sexual Assault (DFSA) (2007)
- 2 April 2007
- Corporate report
Khat Report 2005
- 19 January 2006
- Corporate report
皇冠体育app Advisory Council鈥檚 report - Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971 (2005)
- 19 January 2006
- Corporate report
ACMD's latest Methylamphetamine Advice
- 19 December 2005
- Guidance
Advisory Council on the Misuse of Drugs Methylamphetamine review 2005 executive summary
- 17 November 2005
- Research and analysis
Appendix One: Forensic Science Service 鈥� Methylamphetamine
- 31 October 2004
- Corporate report
皇冠体育app classification of Cannabis under the Misuse of Drugs Act 1971 (2002)
- 31 March 2003
- Policy paper

Published 4 June 2013

Contents

皇冠体育app

ACMD drug-specific reports

Documents

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK

皇冠体育app

Cookies on GOV.UK

ACMD drug-specific reports

Documents

Updates to this page

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK